New award for zirabev (BEVACIZUMAB-BVZR) with pfizer, INC. Period of performance is august 13TH, 2020 to august 12TH, 2021 with four one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0047
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$41,351,134.20
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency, to Pfizer Inc. to provide an uninterrupted supply of Bevacizumab (ZIRABEV) for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through August 12, 2025. The contract value has a ceiling of $41,351,134.20.

The contract was awarded as a single award, unrestricted procurement, with no set-aside designations. Pfizer, as a large pharmaceutical manufacturer, will supply the required quantities of the 100mg and 400mg Bevacizumab drug products through the VA and DoD's respective Pharmaceutical Prime Vendor programs. This contract supports the federal government's healthcare initiatives and readiness requirements by ensuring a reliable supply of this critical oncology medication across multiple government agencies and departments.

Transactions

Action Obligated Date
Add Subcontract Plan P00018 · This modification is issued to incorporate pfizer 2025 subcontracting plan effective for the period of january 1, 2025 - december 31, 2025. $0
Other Administrative Action P00017 · Incorporate federal ceiling price IAW public law 102-585 for zirabev with pfizer. No price changes to the national contract. $0
Exercise an Option P00016 · Exercise option year four for 36E79720D0047 with no price changes. The period of performance is 8/13/2024 - 8/12/2025. $0
Supplemental Agreement for work within scope P00015 · Modification for the supplemental changes to the CRF payment submittal and sales reporting requirements. $0
Other Administrative Action P00014 · 2024 federal ceiling prices $0
Add Subcontract Plan P00013 · This modification is issued to incorporate pfizer's 2024 subcontracting plan effective for the period of january 1, 2024 - december 31, 2024. $0
Exercise an Option P00012 · Exercise option year two for 36E79720D0047 with no price changes. The period of performance is 8/13/2023 - 8/12/2024. $0
Other Administrative Action P00011 · Change of address. New address: 66 hudson blvd. East new york, NY 10001-2192. $0
Other Administrative Action P00010 · Unilateral modification is issued to incorporate updated dscsa language and requirements into VA national contract 36E79720D0047. $0
Other Administrative Action P00009 · Incorporate 2023 fcps. No change in national contract prices. $0
Add Subcontract Plan P00008 · Far 52.219-9 small business subcontracting plan. Implement pfizer, INC. 2023 subk plan. $0
Exercise an Option P00007 · Exercise option year two for 36E79720D0047 with no price changes. The period of performance is 8/13/2022 - 8/12/2023. $0
Add Subcontract Plan P00006 · 2022 subcontracting plan. $0
Supplemental Agreement for work within scope P00005 · 2022 public law pricing updates. National contract price remains as previously awarded. $0
Exercise an Option P00004 · Exercise option year 1 for zirabev (BEVACIZUMAB-BVZR). Period of performance is 8/13/2021 - 8/12/2022. $0
Other Administrative Action P00003 · Administrative point of contact change. $0
Add Subcontract Plan P00002 · This modification is issued to incorporate pfizer INC.'S 2021 subcontracting plan effective january 1, 2021-december 31, 2021. $0
Supplemental Agreement for work within scope P00001 · 2021 public law updates $0
Original award $0
Show all 19

Quick answers

Who was awarded contract 36E79720D0047?

36E79720D0047 was awarded to Pfizer Inc. by National Acquisition Center (Headquarters) on August 13, 2020.

How much is contract 36E79720D0047 worth?

36E79720D0047's own ceiling is $41,351,134.

Who can order from contract 36E79720D0047?

36E79720D0047 is a single award indefinite delivery contract.

Was contract 36E79720D0047 competed?

The extent of competition for 36E79720D0047 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV